[1] 凌箫鸣, 郑英, 张涛, LING Xiao-ming, ZHENG Ying, ZHANG Tao. 宫颈上皮内瘤样病变及鳞癌中p53与MDM2蛋白表达差异性研究 [J]. 肿瘤防治研究 2000.doi:10.3971/j.issn.1000-8578.2000.06.026
[2] Arvanitis DA, Spandidos DA. [J]. Oncology reports 2008.
[3] Tammasino M, Accari R, Calderia. The role of p53 in cervical carcinogenesis [J]. Human Mutation 2003, 21.
[4] Ganzenmueller T, Matthaei M, Muench P, Scheible M, Iftner A, Hiller T, Leiprecht N, Probst S, Stubenrauch F, Iftner T. [J]. Virology 2008.
[5] Waggoner S E. Cervical cancer [J]. LANCET 2003, 361(9376).
[6] Zur Hausen H. Papillomaviruses and cancer:from basic studies to clinical application [J]. Nature Reviews Cancer 2002, 2.
[7] Munoz N, Bosch FX, de-Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. [J]. The New England journal of medicine 2003, 6(6).
[8] Kristiansen E, Jenkins S, Holm R. Coexitence of episomal and integrated HPV16DNA in squamous cell carcinoma of the cervix [J]. Journal of Clinical Pathology 1994, 47.
[9] Thorland EC, Myers SL, Gostout BS, Smith DI. Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. [J]. Oncogene 2003, 8(8).
[10] Haupt Y. Maya R. Kazaz A. Oren M.. MDM2 PROMOTES THE RAPID DEGRADATION OF P53 [J]. Nature 1997, 6630(6630).
[11] Arnd Hengstermann, Laetitia K Linares, Aaron Ciechanover. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells [J]. Proceedings of the National Academy of Sciences(USA) 2001, 98.
[12] Ard PG, Chatterjee C, Kunjibettu S, Adside LR, Gralinski LE, McMahon SB. Transcriptional Regulation of the mdm2 Oncogene by p53 Requires TRRAP Acetyltransferase Complexes. [J]. Molecular and Cellular Biology 2002, 16(16).
[13] Finlay CA, Hinds PW, Levine AJ. The p53 protooncogene can act as a suppresser of transformation [J]. CELL 1989, 57. |
